Sequent Scientific Limited (NSE:SEQUENT)

Market Cap	46.92B
Revenue (ttm)	15.51B
Net Income (ttm)	218.80M
Shares Out	n/a
EPS (ttm)	0.85
PE Ratio	214.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	456,765
Average Volume	1,215,222
Open	188.25
Previous Close	187.85
Day's Range	188.25 - 192.60
52-Week Range	104.65 - 240.70
Beta	1.12
RSI	59.34
Earnings Date	May 21, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology fo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,195
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SEQUENT